Physicians' knowledge of antidepressant withdrawal effects: A survey

Journal of Clinical Psychiatry

Volumn 58, Issue SUPPL. 7, 1997, Pages 28-30

  Young, A H ^a   Currie, Alan ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; DEPRESSION; DRUG EFFECT; GENERAL PRACTICE; HUMAN; MEDICAL EDUCATION; NORMAL HUMAN; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PSYCHIATRIST; UNITED KINGDOM; WITHDRAWAL SYNDROME;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIDEPRESSIVE AGENTS; ATTITUDE OF HEALTH PERSONNEL; CLINICAL COMPETENCE; DEPRESSIVE DISORDER; EDUCATION, MEDICAL, CONTINUING; ENGLAND; FAMILY PRACTICE; HUMANS; PSYCHIATRY; QUESTIONNAIRES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0030738409     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Dilsaver SC, Greden JF, Snider RM. Antidepressant withdrawal syndromes: phenomenology and pathophysiology. Int Clin Psychopharmacol 1987;2:1-19
2. Lejoyeux M, Adés J, Mourad I, et al. Antidepressant withdrawal syndrome: recognition, prevention and management. CNS Drugs 1996;4:278-292
3. Lane RM. Withdrawal symptoms after discontinuation of selective serotonin reuptake inhibitors (SSRIs). Journal of Serotonin Research 1996;3: 75-83
4. Lazowick A. Potential withdrawal syndrome associated with SSRI discontinuation. Ann Pharmacother 1995;29:1284-1285
5. Black DW, Wesner R, Gabel J. The abrupt discontinuation of fluvoxamine in patients with panic disorder. J Clin Psychiatry 1993;54:146-149
6. Keuthen NJ, Cyr P, Ricciardi JA, et al. Medication withdrawal symptoms in obsessive-compulsive disorder patients treated with paroxetine [letter]. J Clin Psychopharmacol 1994;14:206-207
7. Oehrberg S, Christiansen PE, Behnke K, et al, Paroxetine in the treatment of panic disorder: a randomized, double-blind, placebo-controlled study. Br J Psychiatry 1995;167:374-379
8. Committee on Safety of Medicines and Medicines Control Agency. Dystonia and withdrawal symptoms with paroxetine (Seroxat). Current Problems in Pharmacovigilance 1993;19:1
9. Price JS, Waller PC, Wood SM, et al. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal. Br J Clin Pharmacol 1996; 42:757-763
10. Adverse Drug Reactions Advisory Committee (ADRAC). SSRIs and withdrawal syndrome. Australian Adverse Drug Reaction Bulletin 1996;15:3
11. Coupland NJ, Bell CJ, Potokar JP. Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 1996;16:356-362